Drug Science and University College London (UCL) announced a strategic partnership to advance research into MDMA-assisted psychotherapy. This collaboration aims to refine our understanding of how MDMA works in conjunction with psychotherapeutic treatments, addressing concerns that the 'psychotherapy' component may not be fully optimized..

药物科学与伦敦大学学院（UCL）宣布建立战略合作伙伴关系，以推进MDMA辅助心理治疗的研究。这项合作旨在提高我们对MDMA如何与心理治疗相结合的理解，解决“心理治疗”部分可能无法完全优化的担忧。。

MDMA-assisted psychotherapy has shown promise in treating various mental health conditions, but as Professor David Nutt, founder of Drug Science, noted, 'MDMA-assisted therapy has shown great promise, but the recent decision by the FDA highlights the necessity for further research.' As Drug Science stated, the collaboration with UCL seeks to answer these calls for more in-depth exploration of the therapy’s psychotherapeutic elements..

MDMA辅助心理治疗在治疗各种心理健康状况方面显示出前景，但正如药物科学创始人大卫·纳特教授所指出的那样，“MDMA辅助治疗显示出巨大的前景，但FDA最近的决定强调了进一步研究的必要性。”正如《药物科学》所述，与UCL的合作旨在回应这些呼吁，即对治疗的心理治疗要素进行更深入的探索。。

Enhancing MDMA-Assisted Therapy

加强MDMA辅助治疗

The collaboration between Drug Science and UCL will focus on dissecting the complex relationship between MDMA and various psychotherapeutic approaches. According to Prof. Sunjeev Kamboj, Professor of Translational Clinical Psychology at UCL, 'We're at an impasse in understanding how these drugs work at a high level.

药物科学与伦敦大学学院之间的合作将侧重于剖析MDMA与各种心理治疗方法之间的复杂关系。加州大学洛杉矶分校转化临床心理学教授桑杰夫·坎波吉（SunjeevKamboj）表示，“我们在理解这些药物如何在高水平上发挥作用方面陷入僵局。

This is why we are taking an unusual, more qualitative approach to tackle this issue by testing the effects of MDMA in psychotherapists with a strong foundation in theories of psychopathology.'.

这就是为什么我们正在采取一种不寻常的，更定性的方法来解决这个问题，通过测试MDMA对心理治疗师的影响，这些心理治疗师在精神病理学理论上有着坚实的基础。”。

By investigating different therapeutic modalities, this research aims to discern the features of psychotherapy that are most integral to MDMA's effectiveness. This new approach comes at a crucial time following the U.S. Food and Drug Administration's (FDA) decision to halt fast-track approval for MDMA-assisted therapy.

通过调查不同的治疗方式，本研究旨在辨别心理治疗的特征，这些特征对MDMA的有效性至关重要。这种新方法出现在美国食品和药物管理局（FDA）决定停止快速批准MDMA辅助治疗的关键时刻。

While MDMA has demonstrated significant clinical efficacy in trials, the FDA expressed concerns about the therapy’s regulation, potential for misuse and therapist training..

虽然MDMA在试验中显示出显着的临床疗效，但FDA对该疗法的监管，滥用的可能性和治疗师培训表示担忧。。

Pioneering MDMA Research

开创性的MDMA研究

The collaboration builds on decades of pioneering work by the Multidisciplinary Association for Psychedelic Studies (MAPS), which has demonstrated MDMA's potential in a controlled clinical setting. Administered over a 14-week course, MDMA-assisted therapy has been studied in multiple phase 2 and phase 3 trials.

。在为期14周的疗程中，MDMA辅助治疗已在多个2期和3期试验中进行了研究。

Despite these advancements, the FDA's advisory committee raised several critical issues, including the therapy's long-term benefits and therapist oversight, leading to their rejection of MDMA-assisted therapy in June 2024..

尽管取得了这些进展，但FDA咨询委员会提出了几个关键问题，包括治疗的长期益处和治疗师的监督，导致他们在2024年6月拒绝接受MDMA辅助治疗。。

To tackle these challenges, the collaboration between Drug Science and UCL is set to begin recruiting study participants in 2025. Their goal is to develop a practical and standardized understanding of how MDMA can be used most effectively in psychotherapy.

为了应对这些挑战，药物科学与伦敦大学学院之间的合作计划于2025年开始招募研究参与者。他们的目标是对如何在心理治疗中最有效地使用MDMA产生实用和标准化的理解。

Addressing Regulatory Concerns

解决监管问题

In response to the FDA's decision, Drug Science and UCL are focused on addressing key regulatory concerns. The research will explore how MDMA interacts with various therapeutic approaches, aiming to offer solutions to the FDA’s hesitations around combination therapy regulation, generalizability and therapist training.

为了回应FDA的决定，药物科学和UCL专注于解决关键的监管问题。这项研究将探索MDMA如何与各种治疗方法相互作用，旨在为FDA在联合治疗法规，普遍性和治疗师培训方面的犹豫提供解决方案。

Professor Nutt emphasized the importance of this collaboration. 'This partnership is crucial for developing a more refined and evidence-based understanding of MDMA's therapeutic potential.'.

纳特教授强调了这种合作的重要性这种伙伴关系对于发展对MDMA治疗潜力的更精细和循证理解至关重要。”。

The Importance Of A New Treatment

新疗法的重要性

This September, coinciding with National Suicide Prevention Month, several advocacy groups, patients and veterans’ organizations continue to push for progress on the issue, arguing that the drug has helped them overcome severe PTSD symptoms. Some see the approval of such a treatment – the first new one for PTSD in more than two decades – as crucial in light of the veteran suicide crisis, as these therapies can offer a new avenue of treatment to those who have exhausted other options.  .

今年9月，恰逢全国自杀预防月，一些倡导团体、患者和退伍军人组织继续推动这一问题取得进展，认为该药物帮助他们克服了严重的创伤后应激障碍症状。一些人认为，鉴于退伍军人自杀危机，批准这种治疗方法（二十多年来首次针对创伤后应激障碍的新疗法）至关重要，因为这些疗法可以为那些已经用尽其他选择的人提供新的治疗途径。。

Cover image made with AiMarket News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

封面图片由AiMarket新闻和Benzinga API提供给您的数据制作©2024 Benzinga.com。Benzinga不提供投资建议。保留所有权利。